Hemodynamic Stability During Induction of Anaesthesia
Launched by UMEÅ UNIVERSITY · Jan 8, 2018
Trial Information
Current as of July 08, 2025
Completed
Keywords
ClinConnect Summary
40 individuals are enrolled to TCI and RSI groups respectively. The randomization process for preoperative fluid bolus prior to induction of anaesthesia is conducted in respective group at the day of surgery. Preoperative colloid fluid therapy (6 ml/kg LBW, Gelofusine™, Fresenius Kabi Ab, Sweden) is infused rapidly before non-invasive baseline blood pressure (NIBP) measurements in twenty individuals in each group. No other intravenous fluids before induction of anaesthesia.
NIBPs, pulse frequency, peripheral saturation (SpO2) are registered and collected 20 minutes post induction.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 80 individuals over 18 years, body mass index ≤ 35 kg/m2, electively scheduled for breast cancer surgery, endocrinologic surgery (thyroid, parathyroid) and general abdominal surgery.
- Exclusion Criteria:
- • instable angina pectoris at the day of surgery, severe bronchial asthma or COPD.
About Umeå University
Umeå University, a leading research institution in Sweden, is dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on interdisciplinary collaboration, the university harnesses cutting-edge technology and expert knowledge across various fields to address critical health challenges. Its commitment to ethical standards and patient safety ensures that all clinical trials conducted under its auspices are designed to generate robust scientific evidence, ultimately contributing to improved health outcomes and informed medical practices. Umeå University strives to foster a dynamic research environment that supports the development of new therapies and enhances the understanding of complex health issues.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Luleå, , Sweden
Patients applied
Trial Officials
Tomi P Myrberg, MD PhD
Principal Investigator
Umeå University, Norrbotten county concil
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials